Phase 2 Multiple Sclerosis Trial, Not Yet Recruiting NCT07263607 Sponsor: Sichuan Academy of Medical Sciences Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Phase 2 Multiple Sclerosis Trial, Not Yet Recruiting

NCT07263607
Not Yet Recruiting Phase 2

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Adults between 18 and 65 years old, of any gender.
  • People who have been diagnosed with multiple sclerosis (MS) based on a specific set of diagnostic guidelines called the 2017 revised McDonald criteria.
  • People who have been on a stable MS treatment (known as disease-modifying therapy) before joining the trial.
  • People whose level of physical disability, measured by a standard MS scoring tool called the EDSS, falls between 1.0 and 5.5 at the time of screening.
  • People who are able and willing to follow all study procedures, attend follow-up visits, and take the study medication as required.
  • People who are able to provide written consent before any study-related procedures begin.
  • Female participants who are not currently pregnant or breastfeeding, or, if there is a possibility of becoming pregnant, those who agree to use effective birth control throughout the study.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have a known allergy or sensitivity to taurine or any of its ingredients.
  • Women who are currently pregnant or breastfeeding.
  • People who are already taking part in another clinical trial.
  • People who decline to participate in this clinical study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026

Contact this trial

Phone: 86-13645196561

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 2
Sponsor
Sichuan Academy of Medical Sciences
Registry
ClinicalTrials.gov
Start date
1 January 2026
Est. completion
1 July 2029

Primary endpoints

MRI leision activity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov